Page 2 - Neil Maresky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Psyence Group s NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study

NEW YORK, March 12, 2024 Psyence Group Inc , a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, is pleased to.

United statesUnited kingdomJody aufrichtigPsyence biomedNeil mareskyJeremy fefferPsyence biomedical ltdContract research organizationPsyence groupPsyence group incPsyence australia pty ltdNewcourt acquisition corpAustralian health research ethics committeeCanadian securities exchangeWorld health organizationPty ltd

Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division

Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomPsyence biomedAdri bothaWarwick corden lloydNeil mareskyJody aufrichtigAlan friedmanCompany psyence productionUs national exchangeHealth canadaPsyence group incPsyence group financialPsyence biomed ii corpHealth pty ltd lesothoPsyence united kingdom group ltd

Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia - Psyence Biomedical (NASDAQ:PBM)

Jody aufrichtigWarwick corden lloydAdri bothaPsyence biomedNeil mareskyAlan friedmanPty ltdPsyence groupAustralian health research ethics committeePsyence biomedical ltdPsyence united kingdom group ltdPsyence group extra step to reduceHealth ltd lesothoPsyence australiaAdjustment disorderSud agrawal

Psyence Biomedical Ltd Approved to List on Nasdaq following Completion of Business Combination

TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) Psyence Biomedical Ltd. (“Psyence Biomed”) is excited to announce the completion of its merger (the “Business Combination”) with Newcourt Acquisition Corp ("Newcourt"), a

United kingdomUnited statesCommonwealth of australiaNeil mareskyPsyence biomedNewcourt acquisition corpCanadian securities exchangePsyence groupPty ltdPsyence group incPurpose acquisition companyPsyence biomedical ltdPsyence biomed divisionBusiness combinationNote financingSpecial meeting

Psyence Biomedical Ltd Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp

TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) Psyence Group Inc (“Psyence Group”), a clinical-stage life science biotechnology company pioneering the use of…

New yorkUnited statesUnited kingdomCommonwealth of australiaPsyence biomedNeil mareskyBarbara shecterJoe oconnorGabriel friedmanTiff macklemNational postNewcourt acquisition corpPurpose acquisition companyPty ltdPsyence group incPsyence group